<p>Tumor number and size were measured twice a week from the initial DMBA treatment for 20 weeks. (A) WT (n = 20) survived significantly longer than Ts1Rhr (n = 21) mice. **p = 0.007 by Log-rank test. (B) The tumor initiation plotted versus time (weeks) for WT and Ts1Rhr mice. (C) Tumor number per mouse plotted versus time was not different in Ts and WT mice (error bar is SE). From week 9 on, Ts1Rhr developed significantly more tumors per individual compared to WT (ANOVA, *p<0.04).</p
Delay between initiation and promotion on mouse skin was in 1949 reported by Berenblum and Shubik no...
<p>Tumor incidence in DMBA/TPA and OTA/TPA groups is represented in terms of (A) Cumulative number o...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(A) Kaplan Meier curves of tumor-free WT, stathmin heterozygous and KO mice challenged with the 7...
<p><b>A</b>. Individual tumor volume was plotted over time (days) for vehicle and TM5441 (20 mg/kg/d...
<p>At 72 h after PDT, the average volume of treated tumors was significantly different than untreate...
<p>(A, B) Incidence (A) and number (B) of tumors in DMBA/TPA-treated FVB mice of indicated genotypes...
<p><b>Note:</b> Tumor sizes were measured at 39 days post-intratumoral injection (Week 0). Levels of...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>Cohorts of female mice (n = 10) were subjected to classical two-step skin carcinogenesis treatmen...
<p>Mean tumor volume for all surviving mice at days 10, 15, 20, and 25 post-treatment. Mann-Whitney ...
<p>A. Tumor volume (mm<sup>3</sup>) for each individual mouse, as measured from T<sub>2</sub>W MRI i...
<p>A, RTV measurements in survival study comparing the effect of different treatments on tumor devel...
<p>ANOVA with repeated measures were calculated to compare DPOAE thresholds. <i>Jag1<sup>+/−</sup></...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
Delay between initiation and promotion on mouse skin was in 1949 reported by Berenblum and Shubik no...
<p>Tumor incidence in DMBA/TPA and OTA/TPA groups is represented in terms of (A) Cumulative number o...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(A) Kaplan Meier curves of tumor-free WT, stathmin heterozygous and KO mice challenged with the 7...
<p><b>A</b>. Individual tumor volume was plotted over time (days) for vehicle and TM5441 (20 mg/kg/d...
<p>At 72 h after PDT, the average volume of treated tumors was significantly different than untreate...
<p>(A, B) Incidence (A) and number (B) of tumors in DMBA/TPA-treated FVB mice of indicated genotypes...
<p><b>Note:</b> Tumor sizes were measured at 39 days post-intratumoral injection (Week 0). Levels of...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>Cohorts of female mice (n = 10) were subjected to classical two-step skin carcinogenesis treatmen...
<p>Mean tumor volume for all surviving mice at days 10, 15, 20, and 25 post-treatment. Mann-Whitney ...
<p>A. Tumor volume (mm<sup>3</sup>) for each individual mouse, as measured from T<sub>2</sub>W MRI i...
<p>A, RTV measurements in survival study comparing the effect of different treatments on tumor devel...
<p>ANOVA with repeated measures were calculated to compare DPOAE thresholds. <i>Jag1<sup>+/−</sup></...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
Delay between initiation and promotion on mouse skin was in 1949 reported by Berenblum and Shubik no...
<p>Tumor incidence in DMBA/TPA and OTA/TPA groups is represented in terms of (A) Cumulative number o...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...